Achieve Life Sciences publishes cytisinicline receptor study findings

Go back to Achieve Life Sciences publishes cytisinicline receptor study findings
(NASDAQ: ACHV) Delayed: 5.10 +0.25 (5.15%)
Previous Close $4.85    52 Week High
Open $4.94    52 Week Low
Day High $5.43    P/E N/A 
Day Low $4.94    EPS
Volume 2,899,433